{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:36:40Z","timestamp":1788284200940,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009020","name":"University of South China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009020","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014901","name":"Hubei University of Arts and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cca.2025.120154","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:01:45Z","timestamp":1737547305000},"page":"120154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Angiotensin II: A novel biomarker in vascular diseases"],"prefix":"10.1016","volume":"568","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1724-870X","authenticated-orcid":false,"given":"Qin-Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Qian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Wang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120154_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejim.2023.05.020","article-title":"Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases","volume":"115","author":"Villanueva","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0010","doi-asserted-by":"crossref","DOI":"10.1080\/10641963.2017.1377218","article-title":"Hypertension regulating angiotensin peptides in the pathobiology of cardiovascular disease","volume":"40","author":"Hussain","year":"2018","journal-title":"Clinical and Experimental Hypertension (New York N.Y.: 1993)"},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0015","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/ijms23042317","article-title":"Angiotensin Type-2 receptors: transducers of natriuresis in the renal proximal tubule","volume":"23","author":"Carey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13578-023-01063-x","article-title":"Advances in the allostery of angiotensin II type 1 receptor","volume":"13","author":"Zhang","year":"2023","journal-title":"Cell Biosci."},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.83.12.1182","article-title":"Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases","volume":"83","author":"Matsubara","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2025.120154_b0030","doi-asserted-by":"crossref","unstructured":"R. Satou, T. Nakagawa, H. Ido, M. Tomomatsu, F. Suzuki, Y. Nakamura, Angiotensin II and III upregulate body fluid volume of the clam worm Perinereis sp. via angiotensin II receptors in different manners, Peptides 26 (12) (2005) 2452-2457, DOI: 10.1016\/j.peptides.2005.05.017.","DOI":"10.1016\/j.peptides.2005.05.017"},{"key":"10.1016\/j.cca.2025.120154_b0035","doi-asserted-by":"crossref","unstructured":"L. Hansen, T. Wang, The vasopressor action of angiotensin II (ANG II) in ball pythons (Python regius), Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 252 (2021) 110839, DOI: 10.1016\/j.cbpa. 2020.110839.","DOI":"10.1016\/j.cbpa.2020.110839"},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0040","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ki.1997.476","article-title":"Synthesis and effects of active fragments of angiotensin II","volume":"52","author":"Ardaillou","year":"1997","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004872-199917030-00013","article-title":"Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition","volume":"17","author":"Miura","year":"1999","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.cca.2025.120154_b0050","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.3390\/ijms25115779","article-title":"Structural features influencing the bioactive conformation of angiotensin II and angiotensin a: relationship between receptor desensitization, addiction, and the blood-brain barrier","volume":"25","author":"Moore","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00196230","article-title":"Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene","volume":"84","author":"Gaillard-Sanchez","year":"1990","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0060","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/ATVBAHA.124.318374","article-title":"Angiotensinogen as a therapeutic target for cardiovascular and metabolic diseases","volume":"44","author":"Daugherty","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.cca.2025.120154_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/hr.2016.17","article-title":"Structure and functions of angiotensinogen","volume":"39","author":"Lu","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cca.2025.120154_b0070","doi-asserted-by":"crossref","unstructured":"A. M\u00f6ller Petrun, A. Markota, Angiotensin II-Real-Life Use and Literature Review, Medicina (Kaunas, Lithuania) 60 (9) (2024) 1483, DOI: 10.3390\/medicina60091483.","DOI":"10.3390\/medicina60091483"},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120154_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(93)90403-U","article-title":"Levels of angiotensin and molecular biology of the tissue renin angiotensin systems","volume":"43","author":"Phillips","year":"1993","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.98.1.73","article-title":"Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions","volume":"98","author":"van Kats","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2025.120154_b0085","doi-asserted-by":"crossref","unstructured":"G. D\u00fcsterdieck, G. McElwee, Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states, Eur. J. Clin. Invest. 2 (1) (1971) 32-38, DOI: 10.1111\/j.1365-2362.1971.tb00565.x.","DOI":"10.1111\/j.1365-2362.1971.tb00565.x"},{"issue":"Suppl 4","key":"10.1016\/j.cca.2025.120154_b0090","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00005344-199016004-00007","article-title":"The angiotensin II receptor and the actions of angiotensin II","volume":"16","author":"Peach","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0095","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/bst0251041","article-title":"G-protein-coupled receptors for peptide hormones: angiotensin II receptors","volume":"25","author":"Balmforth","year":"1997","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0105","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/01.RES.86.12.1187","article-title":"Cytokine actions of angiotensin II","volume":"86","author":"Sadoshima","year":"2000","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/molpharm.121.000236","article-title":"Update on angiotensin II subtype 2 receptor: focus on peptide and nonpeptide agonists","volume":"99","author":"Ranjit","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cca.2025.120154_b0115","doi-asserted-by":"crossref","unstructured":"M. Paz Ocaranza, J.A. Riquelme, L. Garc\u00eda, J.E. Jalil, M. Chiong, R. Santos, S. Lavandero, Counter-regulatory renin-angiotensin system in cardiovascular disease, Nat Rev Cardiol 17 (2) (2020) 116-129, DOI: 10.1038\/s41569-019-0244-8.","DOI":"10.1038\/s41569-019-0244-8"},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0120","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acs.jmedchem.9b01780","article-title":"The other angiotensin II receptor: AT(2)R as a therapeutic target","volume":"63","author":"Juillerat-Jeanneret","year":"2020","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0130","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3390\/ijms24032213","article-title":"Neurogenic hypertension, the blood-brain barrier, and the potential role of targeted nanotherapeutics","volume":"24","author":"Lamptey","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120154_b0135","doi-asserted-by":"crossref","unstructured":"M. Paul, A. Poyan Mehr, R. Kreutz, Physiology of local renin-angiotensin systems, Physiol. Rev. 86 (3) (2006) 747-803, DOI: 10.1152\/physrev.00036.2005.","DOI":"10.1152\/physrev.00036.2005"},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0140","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/HYPERTENSIONAHA.116.07914","article-title":"How does angiotensin activate hypothalamic neurons essential for controlling sympathetic activity and blood pressure","volume":"68","author":"Mendelowitz","year":"2016","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.cca.2025.120154_b0145","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.3390\/ijms222212305","article-title":"Angiotensin II and the cardiac parasympathetic nervous system in hypertension","volume":"22","author":"Shanks","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jshs.2022.10.004","article-title":"Exercise training attenuates angiotensin II-induced cardiac fibrosis by reducing POU2F1 expression","volume":"12","author":"Feng","year":"2023","journal-title":"J. Sport Health Sci."},{"key":"10.1016\/j.cca.2025.120154_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122320","article-title":"The chromatin remodeling protein BRG1 mediates Ang II induced pro-fibrogenic response in renal fibroblasts","volume":"340","author":"Hong","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2025.120154_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111355","article-title":"Angiotensin II depends on hippo\/YAP signaling to reprogram angiogenesis and promote liver fibrosis","volume":"123","author":"Zhou","year":"2024","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0165","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.joen.2020.03.015","article-title":"Angiotensin II regulates proliferation and function of stem cells of apical papilla","volume":"46","author":"Pizzatto","year":"2020","journal-title":"J. Endod."},{"key":"10.1016\/j.cca.2025.120154_b0170","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221086965","article-title":"Bone Regeneration and angiogenesis by co-transplantation of angiotensin II-pretreated mesenchymal stem cells and endothelial cells in early steroid-induced osteonecrosis of the femoral head","volume":"31","author":"Zhao","year":"2022","journal-title":"Cell Transplant."},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0175","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3174\/ajnr.A7921","article-title":"MR imaging of carotid artery atherosclerosis: updated evidence on high-risk plaque features and emerging trends","volume":"44","author":"Benson","year":"2023","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/cvr\/cvaa042","article-title":"Nox2+ myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1","volume":"117","author":"Molitor","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0185","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.3390\/ijms23063346","article-title":"Pathophysiology of atherosclerosis","volume":"23","author":"Jebari-Benslaiman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0190","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.7150\/thno.87201","article-title":"Re-analysis of single-cell transcriptomics reveals a critical role of macrophage-like smooth muscle cells in advanced atherosclerotic plaque","volume":"14","author":"Gong","year":"2024","journal-title":"Theranostics"},{"issue":"13","key":"10.1016\/j.cca.2025.120154_b0195","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.3390\/ijms22136702","article-title":"Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD","volume":"22","author":"Poznyak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0200","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.numecd.2024.01.019","article-title":"Mitochondrial K(ATP) channel-mediated autophagy contributes to angiotensin II-induced vascular dysfunction in mice","volume":"34","author":"Yin","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.cca.2025.120154_b0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2020.02.002","article-title":"Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways","volume":"157","author":"Piqueras","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.cca.2025.120154_b0210","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/01.RES.0000190400.46267.7e","article-title":"Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II","volume":"97","author":"Takata","year":"2005","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120154_b0215","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1291\/hypres.31.1801","article-title":"Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages","volume":"31","author":"Kanome","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cca.2025.120154_b0220","doi-asserted-by":"crossref","unstructured":"Y. Zhang, Y. Wang, D. Zhou, L.S. Zhang, F.X. Deng, S. Shu, L.J. Wang, Y. Wu, N. Guo, J. Zhou, Z.Y. Yuan, Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT(1)R\/ROS\/p38 MAPK\/ADAM17 pathway, Am. J. Physiol., Cell Physiol. 317 (4) (2019) C776-C787, DOI: 10.1152\/ajpcell.00145.2019.","DOI":"10.1152\/ajpcell.00145.2019"},{"key":"10.1016\/j.cca.2025.120154_b0225","doi-asserted-by":"crossref","unstructured":"L. Wu, K. Chen, J. Xiao, J. Xin, L. Zhang, X. Li, L. Li, J. Si, L. Wang, K. Ma, Angiotensin II induces RAW264.7 macrophage polarization to the M1\u2011type through the connexin 43\/NF\u2011\u03baB pathway, Mol Med Rep 21 (5) (2020) 2103-2112, DOI: 10.3892\/mmr.2020.11023.","DOI":"10.3892\/mmr.2020.11023"},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2019.05.145","article-title":"The role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in angiotensin II-induced macrophage apoptosis and vulnerable plaque formation","volume":"515","author":"Shu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2025.120154_b0235","doi-asserted-by":"crossref","unstructured":"A. St Paul, C.B. Corbett, R. Okune, M.V. Autieri, Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology, Int J Mol Sci 21 (12) (2020) 4525, DOI: 10.3390\/ijms21124525.","DOI":"10.3390\/ijms21124525"},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165912","article-title":"Smooth muscle NADPH oxidase 4 promotes angiotensin II-induced aortic aneurysm and atherosclerosis by regulating osteopontin","volume":"1866","author":"Yu","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0245","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/cells12121621","article-title":"The FAT1 cadherin drives vascular smooth muscle cell migration","volume":"12","author":"Riascos-Bernal","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.cca.2025.120154_b0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.02.022","article-title":"Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis","volume":"346","author":"Jeong","year":"2022","journal-title":"Atherosclerosis"},{"issue":"26","key":"10.1016\/j.cca.2025.120154_b0255","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/eurheartj\/ehaa352","article-title":"Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype","volume":"41","author":"Yang","year":"2020","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.cca.2025.120154_b0260","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.3390\/ijms24098008","article-title":"Tributyrin intake attenuates angiotensin II-induced abdominal aortic aneurysm in LDLR(-\/-) mice","volume":"24","author":"Lin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cca.2025.120154_b0265","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.122.062743","article-title":"Endothelial HDAC1-ZEB2-NuRD complex drives aortic aneurysm and dissection through regulation of protein S-sulfhydration","volume":"147","author":"Luo","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2025.120154_b0270","first-page":"9","article-title":"The murine angiotensin II-induced abdominal aortic aneurysm model: rupture risk and inflammatory progression patterns","volume":"1","author":"Cao","year":"2010","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2025.120154_b0275","doi-asserted-by":"crossref","unstructured":"Z. Wu, Z. Xu, H. Pu, A. Ding, J. Hu, J. Lei, C. Zeng, P. Qiu, J. Qin, X. Wu, B. Li, X. Wang, X. Lu, NINJ1 Facilitates Abdominal Aortic Aneurysm Formation via Blocking TLR4-ANXA2 Interaction and Enhancing Macrophage Infiltration, Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024) e2306237, DOI: 10.1002\/advs.202306237.","DOI":"10.1002\/advs.202306237"},{"issue":"15","key":"10.1016\/j.cca.2025.120154_b0280","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1111\/jcmm.16757","article-title":"CCL7 contributes to angiotensin II-induced abdominal aortic aneurysm by promoting macrophage infiltration and pro-inflammatory phenotype","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cca.2025.120154_b0285","article-title":"AT1R regulates macrophage polarization through YAP and regulates aortic dissection incidence","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/CIRCULATIONAHA.123.065202","article-title":"LXR\u03b1 promotes abdominal aortic aneurysm formation through UHRF1 epigenetic modification of miR-26b-3p","volume":"150","author":"Guo","year":"2024","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0295","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s12276-022-00815-y","article-title":"Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis","volume":"54","author":"Gao","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cca.2025.120154_b0300","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/2157355","article-title":"HMGB2 Deficiency mitigates abdominal aortic aneurysm by suppressing Ang-II-caused ferroptosis and inflammation via NF-\u03ba\u03b2 pathway","volume":"2023","author":"Wu","year":"2023","journal-title":"Mediators Inflamm."},{"issue":"13","key":"10.1016\/j.cca.2025.120154_b0305","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1111\/jcmm.16485","article-title":"MicroRNA-199a-5p aggravates angiotensin II-induced vascular smooth muscle cell senescence by targeting Sirtuin-1 in abdominal aortic aneurysm","volume":"25","author":"Tao","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0310","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1161\/ATVBAHA.122.318400","article-title":"DOCK2 deficiency attenuates abdominal aortic aneurysm formation-brief report","volume":"43","author":"Guo","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2025.120154_b0315","article-title":"Nox1\/PAK1 is required for angiotensin II-induced vascular inflammation and abdominal aortic aneurysm formation","volume":"79","author":"He","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.cca.2025.120154_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117882","article-title":"Role of c-Abl in Ang II-induced aortic dissection formation: Potential regulatory efficacy on phenotypic transformation and apoptosis of VSMCs","volume":"256","author":"Zhou","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0325","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.7150\/ijbs.63593","article-title":"Pharmacologic IRE1\u03b1 kinase inhibition alleviates aortic dissection by decreasing vascular smooth muscle cells apoptosis","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70147","article-title":"Deficiency of ATF3 facilitates both angiotensin II-induced and spontaneously formed aortic aneurysm and dissection development by activating cGAS-STING pathway","volume":"15","author":"Du","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0335","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10735-013-9558-8","article-title":"Angiotensin-II induces phosphorylation of ERK1\/2 and promotes aortic adventitial fibroblasts differentiating into myofibroblasts during aortic dissection formation","volume":"45","author":"Wang","year":"2014","journal-title":"J. Mol. Histol."},{"issue":"13","key":"10.1016\/j.cca.2025.120154_b0340","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.121.058173","article-title":"Second heart field-derived cells contribute to angiotensin II-mediated ascending aortopathies","volume":"145","author":"Sawada","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0345","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/ijms24010172","article-title":"Hydroxysafflower yellow A inhibits vascular adventitial fibroblast migration via NLRP3 inflammasome inhibition through autophagy activation","volume":"24","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0350","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00418-016-1512-x","article-title":"TRPV1 attenuates intracranial arteriole remodeling through inhibiting VSMC phenotypic modulation in hypertension","volume":"147","author":"Zhang","year":"2017","journal-title":"Histochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0355","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/ATVBAHA.117.310694","article-title":"MicroRNA-21 knockout exacerbates angiotensin II-induced thoracic aortic aneurysm and dissection in mice with abnormal transforming growth factor-\u03b2-SMAD3 signaling","volume":"38","author":"Huang","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000506396","article-title":"Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017","volume":"54","author":"Krishnamurthi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0365","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","article-title":"Ischemic stroke","volume":"134","author":"Feske","year":"2021","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.cca.2025.120154_b0370","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.bbadis.2018.08.008","article-title":"Endothelial cell senescence in aging-related vascular dysfunction","volume":"1865","author":"Jia","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0375","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/jnc.15807","article-title":"Iron, ferroptosis, and ischemic stroke","volume":"165","author":"Guo","year":"2023","journal-title":"J. Neurochem."},{"issue":"15","key":"10.1016\/j.cca.2025.120154_b0380","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033341","article-title":"Vascular aging in ischemic stroke","volume":"13","author":"Liu","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.cca.2025.120154_b0385","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu. Rev. Pathol."},{"issue":"20","key":"10.1016\/j.cca.2025.120154_b0390","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/CIRCULATIONAHA.115.016457","article-title":"Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability","volume":"132","author":"Wang","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0395","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.ATV.0000164624.00099.e7","article-title":"A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65","volume":"25","author":"Zhang","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2025.120154_b0400","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fendo.2019.00584","article-title":"Role of aldosterone and mineralocorticoid receptor in cardiovascular aging","volume":"10","author":"Gorini","year":"2019","journal-title":"Front Endocrinol (lausanne)"},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0405","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ajh\/hpaa218","article-title":"Angiotensin II and amyloid-\u03b2 synergistically induce brain vascular smooth muscle cell senescence","volume":"34","author":"Bai","year":"2021","journal-title":"Am. J. Hypertens."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0410","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.119.316453","article-title":"Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability","volume":"127","author":"Tang","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0415","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00394-014-0749-1","article-title":"Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice","volume":"54","author":"Tajima","year":"2015","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.cca.2025.120154_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134684","article-title":"Angiotensin II down-regulates transferrin receptor 1 and ferroportin 1 expression in Neuro-2a cells via activation of type-1 receptor","volume":"716","author":"Chen","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0425","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/nu12030668","article-title":"JNK\/p66Shc\/ITCH signaling pathway mediates angiotensin II-induced ferritin degradation and labile iron pool increase","volume":"12","author":"Borkowska","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0430","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cca.2025.120154_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105877","article-title":"TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats","volume":"174","author":"Mowry","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/09727531231182554","article-title":"A review on neuroinflammatory pathway mediating through Ang-II\/AT1 receptors and a novel approach for the treatment of cerebral ischemia in combination with ARB's and ceftriaxone","volume":"31","author":"Rao","year":"2024","journal-title":"Ann. Neurosci."},{"issue":"7","key":"10.1016\/j.cca.2025.120154_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180738","article-title":"Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged rats","volume":"12","author":"Bennion","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2025.120154_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109701","article-title":"GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K\/AKT signaling","volume":"122","author":"Yue","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0455","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/STROKEAHA.121.035850","article-title":"New insights into cerebrovascular pathophysiology and hypertension","volume":"53","author":"Webb","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.cca.2025.120154_b0460","doi-asserted-by":"crossref","unstructured":"T.J. Guzik, R.M. Touyz, Oxidative Stress, Inflammation, and Vascular Aging in Hypertension, Hypertension 70 (4) (2017) 660-667, DOI: 10.1161\/HYPERTENSIONAHA.117.07802.","DOI":"10.1161\/HYPERTENSIONAHA.117.07802"},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0465","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2025.120154_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121573","article-title":"Effect of bempedoic acid on angiotensin-II induced hypertension and vascular tissue remodelling in renal hypertensive rats through AMPK multiple signalling pathways modulation","volume":"320","author":"Ahmed","year":"2023","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0475","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.suc.2023.05.007","article-title":"Nonatherosclerotic renovascular hypertension","volume":"103","author":"Dalman","year":"2023","journal-title":"Surg. Clin. North Am."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0480","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00018-022-04623-5","article-title":"YAP-galectin-3 signaling mediates endothelial dysfunction in angiotensin II-induced hypertension in mice","volume":"80","author":"Pang","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0485","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41440-023-01480-y","article-title":"Enhancement of angiotensin II type 1 receptor-associated protein in the paraventricular nucleus suppresses angiotensin II-dependent hypertension","volume":"47","author":"Sotozawa","year":"2024","journal-title":"Hypertens. Res."},{"issue":"23","key":"10.1016\/j.cca.2025.120154_b0490","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011911","article-title":"Attenuation of angiotensin II-induced hypertension in BubR1 low-expression mice via repression of angiotensin II receptor 1 overexpression","volume":"8","author":"Aoyagi","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0495","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.120.11941","article-title":"Angiotensin II type 2 receptor: a target for protection against hypertension, metabolic dysfunction, and organ remodeling","volume":"77","author":"Fatima","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0500","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11906-018-0823-9","article-title":"Dysregulation of the renin-angiotensin system and the vasopressinergic system interactions in cardiovascular disorders","volume":"20","author":"Szczepanska-Sadowska","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"issue":"7\u20139","key":"10.1016\/j.cca.2025.120154_b0505","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2021.0047","article-title":"Renal NOXA1\/NOX1 signaling regulates epithelial sodium channel and sodium retention in angiotensin II-induced hypertension","volume":"36","author":"Vendrov","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0510","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.120.16428","article-title":"S1P (Site-1 Protease)-induced release of the soluble prorenin receptor in hypertension: do all roads lead to Ang II (Angiotensin II)","volume":"77","author":"Chappell","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2025.120154_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106030","article-title":"Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury","volume":"175","author":"Majumder","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0520","doi-asserted-by":"crossref","first-page":"F202","DOI":"10.1152\/ajprenal.00139.2023","article-title":"Angiotensin II acts through Rac1 to upregulate pendrin: role of NADPH oxidase","volume":"326","author":"Pham","year":"2024","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0525","first-page":"H1027","article-title":"Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways","volume":"316","author":"Singh","year":"2019","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"key":"10.1016\/j.cca.2025.120154_b0530","doi-asserted-by":"crossref","unstructured":"A. Chrysanthopoulou, E. Gkaliagkousi, A. Lazaridis, S. Arelaki, P. Pateinakis, M. Ntinopoulou, A. Mitsios, C. Antoniadou, C. Argyriou, G.S. Georgiadis, V. Papadopoulos, A. Giatromanolaki, K. Ritis, P. Skendros, Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension, JCI Insight 6 (18) (2021) e148668 [pii], DOI: 10.1172\/jci.insight.148668.","DOI":"10.1172\/jci.insight.148668"},{"key":"10.1016\/j.cca.2025.120154_b0535","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6512485","article-title":"Effects of angiotensin-(1-7) and angiotensin II on acetylcholine-induced vascular relaxation in spontaneously hypertensive rats","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cca.2025.120154_b0540","doi-asserted-by":"crossref","unstructured":"M.A. Olivencia, M. Mart\u00ednez-Casales, D.A. Peraza, A.B. Garc\u00eda-Redondo, G. Mond\u00e9jar-Parre\u00f1o, R. Hernanz, M. Salaices, A. Cogolludo, M.W. Pennington, C. Valenzuela, A.M. Briones, K(V) 1.3 channels are novel determinants of macrophage-dependent endothelial dysfunction in angiotensin II-induced hypertension in mice, Br. J. Pharmacol. 178 (8) (2021) 1836-1854, DOI: 10.1111\/bph.15407.","DOI":"10.1111\/bph.15407"},{"key":"10.1016\/j.cca.2025.120154_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170863","article-title":"COX\/iNOS dependence for angiotensin-II-induced endothelial dysfunction","volume":"157","author":"Lopes","year":"2022","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0550","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41440-024-01610-0","article-title":"Mitochondrial fission inhibition protects against hypertension induced by angiotensin II","volume":"47","author":"Preston","year":"2024","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cca.2025.120154_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102072","article-title":"The promoting role of Cx43 on the proliferation and migration of arterial smooth muscle cells for angiotensin II-dependent hypertension","volume":"70","author":"Gao","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2025.120154_b0560","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.niox.2019.10.007","article-title":"Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension","volume":"94","author":"Sharma","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.cca.2025.120154_b0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.25259\/Cytojournal_86_2024","article-title":"Nuclear receptor subfamily 4 group a member 1 eases angiotensin II-arose oxidative stress in vascular smooth muscle cell by boosting nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing 3 transcription","volume":"21","author":"Shen","year":"2024","journal-title":"Cytojournal"},{"key":"10.1016\/j.cca.2025.120154_b0570","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.124.24098","article-title":"Reduced AT(2)R signaling contributes to endothelial dysfunction after preeclampsia","author":"Schwartz","year":"2024","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.cca.2025.120154_b0575","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029355","article-title":"Clinical outcomes in hypertensive emergency: a systematic review and meta-analysis","volume":"12","author":"Siddiqi","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0580","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-0037-1606214","article-title":"Pathology and pathobiology of pulmonary hypertension","volume":"38","author":"Guignabert","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120154_b0585","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCULATIONAHA.113.004555","article-title":"Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay","volume":"129","author":"Huertas","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0590","first-page":"357","article-title":"Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension","volume":"1","author":"Xu","year":"2011","journal-title":"Compr. Physiol."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0595","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCRESAHA.111.241299","article-title":"Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease","volume":"109","author":"Noureddine","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0600","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbrc.2020.02.064","article-title":"Septin4 as an autophagy modulator regulates Angiotensin-II mediated VSMCs proliferation and migration","volume":"525","author":"Wang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.cca.2025.120154_b0605","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacbts.2021.09.006","article-title":"\u03b2-arrestin-mediated angiotensin II Type1receptor activation promotes pulmonary vascular remodeling in pulmonary hypertension","volume":"6","author":"Ma","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cca.2025.120154_b0610","doi-asserted-by":"crossref","unstructured":"A. Chowdhury, J. Sarkar, P. Kanti Pramanik, T. Chakraborti, S. Chakraborti, Role of PKC\u03b6-NADPH oxidase signaling axis in PKC\u03b1-mediated Gi\u03b12 phosphorylation for inhibition of adenylate cyclase activity by angiotensin II in pulmonary artery smooth muscle cells, Cell Biol. Int. 44 (5) (2020) 1142-1155, DOI: 10.1002\/cbin.11311.","DOI":"10.1002\/cbin.11311"},{"issue":"7","key":"10.1016\/j.cca.2025.120154_b0615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1096\/fj.04-2890fje","article-title":"Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system","volume":"19","author":"Krick","year":"2005","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0620","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4238\/2015.March.6.17","article-title":"Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension","volume":"14","author":"Wang","year":"2015","journal-title":"GENET. Mol. Res."},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0625","doi-asserted-by":"crossref","DOI":"10.1042\/CS20120081","article-title":"Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease","volume":"123","author":"Shrikrishna","year":"2012","journal-title":"Clin. Sci. (London England: 1979)"},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0630","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/2150135119825599","article-title":"Early experience with sacubitril\/valsartan in adult patients with congenital heart disease","volume":"10","author":"Lluri","year":"2019","journal-title":"World J. Pediatric Congenital Heart Surgery"},{"key":"10.1016\/j.cca.2025.120154_b0635","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cca.2025.120154_b0640","article-title":"Early detection of type 2 diabetes risk: limitations of current diagnostic criteria","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0645","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2022.07.002","article-title":"Ameliorating cardiovascular risk in patients with type 2 diabetes","volume":"52","author":"Motairek","year":"2023","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0650","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4239\/wjd.v14.i3.170","article-title":"AT1 receptor downregulation: a mechanism for improving glucose homeostasis","volume":"14","author":"Lopez","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.cca.2025.120154_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173122","article-title":"12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy","volume":"879","author":"Dong","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0660","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-019-44194-3","article-title":"Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120154_b0665","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.12659\/MSM.900842","article-title":"Angiotensin II promotes the development of carotid atherosclerosis in type 2 diabetes patients via regulating the T cells activities: a cohort study","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit."},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0670","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/cbf.3879","article-title":"Angiotensin II reduces glyoxalase 1 activity and expression in vascular smooth muscle cells: implications for diabetic vascular complications","volume":"41","author":"K\u0131r\u00e7a","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0675","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcjd.2017.09.011","article-title":"The divergent cardiovascular effects of angiotensin-converting enzyme inhibitors and angiotensin II Type 1 receptor blockers in adult patients with type 2 diabetes mellitus","volume":"42","author":"Strauss","year":"2018","journal-title":"Can. J. Diabetes"},{"issue":"1","key":"10.1016\/j.cca.2025.120154_b0680","doi-asserted-by":"crossref","first-page":"18978","DOI":"10.1038\/s41598-024-69437-w","article-title":"Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy","volume":"14","author":"Das","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120154_b0685","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0292","article-title":"RAAS in diabetic retinopathy: mechanisms and therapies","volume":"68","author":"Li","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.cca.2025.120154_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107902","article-title":"Angiotensin II and aldosterone activate retinal microglia","volume":"191","author":"Rana","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cca.2025.120154_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107753","article-title":"The renin-angiotensin system and the retinal neurovascular unit: a role in vascular regulation and disease","volume":"187","author":"Phipps","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.10.2.16","article-title":"Longitudinal testing of retinal blood flow in a mouse model of hypertension by laser speckle flowgraphy","volume":"10","author":"Tamplin","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.cca.2025.120154_b0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2017.12.007","article-title":"Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals \u2013 a randomized double- blind pre-clinical study","volume":"346","author":"Ahmed","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0710","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II-mediated microvascular thrombosis","volume":"56","author":"Senchenkova","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0715","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147191","article-title":"KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression","volume":"132","author":"Tang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0720","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1160\/TH04-10-0701","article-title":"Angiotensin II enhances thrombosis development in renovascular hypertensive rats","volume":"93","author":"Mogielnicki","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cca.2025.120154_b0725","first-page":"1012","article-title":"Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets","volume":"94","author":"Utsugisawa","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0730","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316659618","article-title":"Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis","volume":"17","author":"Li","year":"2016","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"7","key":"10.1016\/j.cca.2025.120154_b0735","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/abbs\/gmv047","article-title":"Angiotensin II induces an increase in MMP-2 expression in idiopathic ascending aortic aneurysm via AT1 receptor and JNK pathway","volume":"47","author":"Wang","year":"2015","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"3","key":"10.1016\/j.cca.2025.120154_b0740","first-page":"1426","article-title":"Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages","volume":"8","author":"Wu","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.cca.2025.120154_b0745","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/ggi.12167","article-title":"Serum levels of renin-angiotensin system components in acute stroke patients","volume":"14","author":"Mogi","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"issue":"6","key":"10.1016\/j.cca.2025.120154_b0750","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12517","article-title":"Yes-associated protein mediates angiotensin II-induced vascular smooth muscle cell phenotypic modulation and hypertensive vascular remodelling","volume":"51","author":"Lin","year":"2018","journal-title":"Cell Prolif."},{"issue":"8","key":"10.1016\/j.cca.2025.120154_b0755","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"de Man","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.cca.2025.120154_b0760","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jdiacomp.2017.07.002","article-title":"Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus","volume":"31","author":"Min","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0765","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ab.2007.08.038","article-title":"Bioluminescence immunoassay for angiotensin II using aequorin as a label","volume":"371","author":"Qu","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2025.120154_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122740","article-title":"A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma","volume":"1179","author":"Chen","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.cca.2025.120154_b0775","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymeth.2012.02.006","article-title":"Duplexed iMALDI for the detection of angiotensin I and angiotensin II","volume":"56","author":"Mason","year":"2012","journal-title":"Methods"},{"issue":"10","key":"10.1016\/j.cca.2025.120154_b0780","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.25045","article-title":"Analytical interference in chemiluminescence assay-measured angiotensin I, angiotensin II, aldosterone, and renin","volume":"38","author":"Xu","year":"2024","journal-title":"J. Clin. Lab. Anal."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:21:46Z","timestamp":1740378106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":156,"alternative-id":["S0009898125000336"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120154","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II: A novel biomarker in vascular diseases","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120154"}}